Clinical research is engaged in advancing the knowledge and treatment of acute and chronic disease states.
Investigative areas include the study of infectious diseases, primary care, critical care, pediatrics, drug information, and scholarship of teaching and learning.
Infectious Diseases
Studies are addressing antimicrobial stewardship, pharmacokinetics/pharmacodynamics, multidrug-resistant organisms, and emerging infections.
Primary Researchers
Justin Andrade, PharmD, BCIDP
Areas of interest include integration of in vitro pharmacokinetic/pharmacodynamic targets for beta-lactams in special patient populations and evaluation of novel antimicrobial agents in various clinical practice settings.
Sharon Blum, PharmD, BCIDP
Areas of interest include antimicrobial stewardship metrics and outcomes and pragmatic studies of anti-infectives.
Eris Cani, PharmD, BCPS, BCIDP
Areas of interest include multi-drug-resistant gram-negative infections, antimicrobial stewardship, and HIV.
Tyler Maxwell, PharmD, BCIDP, AAHIVP
Areas of interest include the Infection of Trisomy-21 and Disomy-21 cells and observed downstream effects; evaluation of the effectiveness and sustainability of a pharmacist-prompted antibiotic time-out program; continuous infusion of ketamine for sedation in mechanically ventilated patients infected with SARS-CoV-2; outcomes and risk factors for fungal coinfections in COVID-19 patients; evaluation of clinical outcomes of empiric antimicrobial regimens for patients at low risk of methicillin-resistant Staphylococcus aureus; outcomes associated with broad-spectrum antibiotic use in a level III neonatal intensive care units.
Primary Care
Here, the concentration is on advancing patient-centered care through evidence-based practice and interdisciplinary collaboration. Studies are addressing chronic disease management, anticoagulation therapy, metabolic disorders, and pharmacist-led interventions with an emphasis on improving health outcomes across diverse populations. Other research is exploring innovative approaches to managing chronic conditions such as diabetes, hypertension, and cardiovascular disease, while also addressing the evolving role of pharmacists in primary care settings.
Primary Researchers
Roman Fazylov, PharmD, BCPS
Areas of interest include combination antibiotics for multi-drug resistant bacteria; patient-tailored empiric therapy for HCAP: moving away from the HCAP model; anticoagulant use in obesity; and antibiotic pharmacokinetics and therapeutic drug monitoring.
Michelle Jakubovics, PharmD, BCPS, BCGP
Area of interest includes incidence of hyper/hypoglycemia in patients continuing oral antidiabetic medications in the internal medicine setting; implementation of an opioid stewardship protocol in a long-term care facility; hypoglycemia rates and management with different Insulin Detemir administration times; safety and efficacy of Warfarin versus Apixaban in patients with severe renal impairment use of direct oral anticoagulants in obese patients.
Leah (Mahsa) Moradi, PharmD, BCPS
Areas of interest include incidence of hyper/hypoglycemia in patients continuing oral glucose-lowering therapies in the inpatient setting; evaluation of appropriate adherence to FDA approved dosing regimens for direct-acting oral anticoagulants.
Joanne Son, PharmD, BCACP, AAHIVP
Area of interest includes evaluating the effect of timing on point-of-care (POC) testing of INR; evaluation of safety and efficacy of chlorthalidone 50 mg; impact of pharmacist-led discharge medication reconciliation and clinical medication review to adhere to The Joint Commission Comprehensive Stroke Center certification quality measures
.jpg)
Keith Veltri, PharmD, BCPS, BCGP
Areas of interest involve several areas of internal medicine pharmacotherapy including infectious diseases, cardiology, nephrology, endocrinology, gastroenterology, respiratory disorders, psychology and vaccinations.
Critical Care
Clinical research, scholarly publications and innovative practice models are devoted to advancing critical care, addressing key challenges in acute and chronic care settings, with the objective of optimizing pharmacotherapy and improving patient outcomes.
Primary Researchers
Michael Liu, PharmD, MBA, BCCCP, BCNSP, BCPS
Areas of interest include adult critical care medicine.
Amy Wang, PharmD, MBA, BCPS
Areas of interest include optimal dose of furosemide in heart failure exacerbation, efficacy of lower dose apixaban in atrial fibrillation, and impact of real-life legislative visits on pharmacy students’ advocacy skills.
Pediatrics
Pediatric research is committed to improving medication safety, efficacy, and therapeutic outcomes for children across a variety of care settings. This work includes neonatal pharmacotherapy, pediatric infectious diseases, immunization practices, and emergency care interventions all designed to advance pediatric pharmacy practice and enhancing the quality of care for our youngest patients.
Primary Researchers
.jpeg)
Tamara Hernandez Oz, PharmD, MBA, BCPPS
Areas of interest include development of discharge counseling program and discharge medication reconciliation process for pediatric patients; development of pediatric ketogenic diet drug use guidelines; development of Alteplase use policy in pediatric patients with pulmonary embolism; evaluation of enoxaparin and apixaban for the prevention of venous thromboembolism in patients with COVID-19; the effect of Pitavastatin on the blood glucose levels in patients with or without type 2 diabetes mellitus; implementation of a precision-dosing regimen for patients receiving treatment with intravenous immune globulin
Drug Information
The emphasis is on enhancing evidence-based decision-making in clinical settings through systematic literature reviews, comparative effectiveness studies, and the integration of emerging technologies such as artificial intelligence in pharmacy practice. With interests spanning internal medicine and global health, this research supports informed therapeutic choices and contributes to the advancement of clinical pharmacy knowledge.
Primary Researchers
Anastasiya Shor, Pharm.D., BCPS
Dr. Shor is interested in conducting systematic literature reviews and uncovering the latest evidence-based practices within the fields of drug information and internal medicine. Her additional interests include artificial intelligence and real-world evidence applications in healthcare and global health initiatives.
